Co-pathological connected primary neurons in a microfluidic device for Alzheimer studies.
暂无分享,去创建一个
Anja Kunze | Robert Meissner | P. Renaud | A. Kunze | Philippe Renaud | R. Meissner | Serena Brando | S. Brando
[1] A. Lees,et al. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions , 2004, Acta Neuropathologica.
[2] Dong Hou Kim,et al. BACE inhibitor reduces APP-β-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration , 2006, Neurobiology of Disease.
[3] I. Grundke‐Iqbal,et al. Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid‐treated SY5Y cells , 2001, FEBS letters.
[4] C. Arias,et al. Okadaic Acid Induces Early Changes in Microtubule‐Associated Protein 2 and γ Phosphorylation Prior to Neurodegeneration in Cultured Cortical Neurons , 1993, Journal of neurochemistry.
[5] D. Small. Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression? , 2008, Trends in molecular medicine.
[6] G. Leuba,et al. Contribution of neural networks to Alzheimer disease's progression , 2009, Brain Research Bulletin.
[7] Erin M. Schuman,et al. Microfluidic Local Perfusion Chambers for the Visualization and Manipulation of Synapses , 2010, Neuron.
[8] L. Mucke,et al. A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.
[10] Amir Shamloo,et al. Matrix density mediates polarization and lumen formation of endothelial sprouts in VEGF gradients. , 2010, Lab on a chip.
[11] S. Love,et al. Tau hyperphosphorylation affects Smad 2/3 translocation , 2009, Neuroscience.
[12] Thomas M Pearce,et al. Microtechnology: meet neurobiology. , 2007, Lab on a chip.
[13] Noo Li Jeon,et al. Micro-scale and microfluidic devices for neurobiology , 2010, Current Opinion in Neurobiology.
[14] Ralph G Nuzzo,et al. Guiding neuron development with planar surface gradients of substrate cues deposited using microfluidic devices. , 2010, Lab on a chip.
[15] Xiongwei Zhu,et al. Involvement of Oxidative Stress in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.
[16] Wenming Liu,et al. Microfluidics: a new cosset for neurobiology. , 2009, Lab on a chip.
[17] J. Simpkins,et al. An okadaic acid-induced model of tauopathy and cognitive deficiency , 2010, Brain Research.
[18] Richard S. J. Frackowiak,et al. Alzheimer's patients engage an alternative network during a memory task , 2005, Annals of neurology.
[19] A. Delacourte. Tau pathology and neurodegeneration: an obvious but misunderstood link. , 2008, Journal of Alzheimer's disease : JAD.
[20] N. Shahani,et al. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. , 2005, Biochimica et biophysica acta.
[21] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[22] Heinz-Georg Jahnke,et al. A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring. , 2010, Biosensors & bioelectronics.
[23] Eytan Ruppin,et al. Neuronal-Based Synaptic Compensation: A Computational Study in Alzheimer's Disease , 1996, Neural Computation.
[24] Michele Giugliano,et al. Micropatterning neural cell cultures in 3D with a multi-layered scaffold. , 2011, Biomaterials.
[25] D. Galasko,et al. Intracellular Aβ is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines , 2002, Neurobiology of Aging.